| 000 | 00774nam a2200229Ia 4500 | ||
|---|---|---|---|
| 008 | 170220s9999||||xx |||||||||||||| ||und|| | ||
| 020 | _a978-1-4939-1252-0 | ||
| 022 | _a2210-738X | ||
| 040 | _aNISER LIBRARY | ||
| 041 | _aEnglish/International | ||
| 100 | _aLawrence X. Yu, Bing V. Li | ||
| 245 | _aFDA Bioequivalence Standards | ||
| 260 |
_bSpringer New York _c2014 |
||
| 300 | _bContributed volume | ||
| 440 |
_aAAPS Advances in the Pharmaceutical Sciences Series _n13 |
||
| 650 | _aBiomedical and Life Sciences | ||
| 650 | _aPharmaceutical Sciences/Technology | ||
| 710 | _aThe United States Government | ||
| 856 | _uhttp://dx.doi.org/10.1007/978-1-4939-1252-0 | ||
| 856 | _uhttp://link.springer.com/openurl?genre=book&isbn=978-1-4939-1251-3 | ||
| 942 | _cEB | ||
| 999 |
_c27010 _d27010 |
||